First Bank & Trust’s Kyntra Bio KYNB Stock Holding History

First Bank & Trust’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-2	Closed	-$1K	–	253
2017 Q1	$1K	Hold	2	–	–	﹤0.01%	239
2016 Q4	$1K	Buy	+2	New	+$999	﹤0.01%	250

Other funds holding KYNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIM

Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

First Bank & Trust's KYNB Position: Q2 2017 in Review

First Bank & Trust sold out of Kyntra Bio (KYNB) in Q2 2017, closing a stake of 2 shares — an estimated $1K sold.

First Bank & Trust first reported a position in KYNB in Q4 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2017. 151 funds tracked by Wall St. Rank hold KYNB as of Q2 2017.

First Bank & Trust reported no remaining Kyntra Bio position as of Q2 2017 after selling out during the quarter.
First Bank & Trust sold 2 Kyntra Bio shares in Q2 2017, an estimated $1K.
First Bank & Trust first reported a position in Kyntra Bio in Q4 2016 and held it in 2 quarters.
First Bank & Trust's Kyntra Bio position peaked at $1K in Q1 2017.
151 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2017.

Based on First Bank & Trust's 13F filing for Q2 2017, filed 31 Jul 2017.